This early phase I trial studies how well 3D ultrasound microvessel imaging works for the diagnosis of breast mass. The 3D ultrasound microvessel imaging technology demonstrates significantly increased vessel detection sensitivity over conventional doppler methods without the need of using contrast agents. This study may improve cancer diagnosis and reduce unnecessary biopsy on benign tumors.
Age range
18 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Ultrasound diagnostic accuracy using McNemar's test
Timeframe: Up to 1 year
Ultrasound parameters sensitivity using McNemar's test
Timeframe: Up to 1 year
Ultrasound parameters specificity using McNemar's test
Timeframe: Up to 1 year
Ultrasound parameters positive predictive value using McNemar's test
Timeframe: Up to 1 year
Ultrasound parameters negative predictive value using McNemar's test
Timeframe: Up to 1 year
Ultrasound parameters accuracy using McNemar's test
Timeframe: Up to 1 year
Ultrasound parameters calculated by McNemar's test
Timeframe: Up to 1 year
Ultrasound parameters vs. Breast Image Reporting using McNemar's test
Timeframe: Up to 1 year